tadalafil has been researched along with Breathlessness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chabot, F; Chaouat, A; Gomez, E; Guillaumot, A; Petitpain, N; Ribeiro Baptista, B; Valentin, S; Yelehé-Okouma, M | 1 |
| El-Kersh, K; Jalil, BA; Smith, JS | 1 |
| Ashworth, AJ | 1 |
3 other study(ies) available for tadalafil and Breathlessness
| Article | Year |
|---|---|
Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.
Topics: 4-Aminopyridine; Antihypertensive Agents; Dyspnea; Female; Humans; Hypertension, Pulmonary; Middle Aged; Multiple Sclerosis; Phenylpropionates; Potassium Channel Blockers; Pyridazines; Tadalafil | 2019 |
A 34-Year-Old Woman With Hoarseness of Voice and an Abnormal Echocardiogram.
Topics: Adult; Dyspnea; Echocardiography; Female; Heart Atria; Heart Ventricles; Hoarseness; Humans; Laryngoscopy; Lung; Patient Care Management; Pulmonary Arterial Hypertension; Pulmonary Artery; Severity of Illness Index; Tadalafil; Tomography, X-Ray Computed; Treatment Outcome; Vasodilator Agents; Vocal Cord Paralysis | 2019 |
Enhanced recovery from respiratory infection following treatment with a PDE-5 inhibitor: a single case study.
Topics: Carbolines; Dyspnea; Exercise Tolerance; Humans; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Pneumonia; Recovery of Function; Tadalafil | 2012 |